PNC FINANCIAL SERVICES GROUP, INC. - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q3 2019$120,000
-7.7%
60,2800.0%0.00%
Q2 2019$130,000
-27.8%
60,280
+6.0%
0.00%
Q1 2019$180,000
+28.6%
56,880
+1.7%
0.00%
Q4 2018$140,000
-36.4%
55,940
+2.3%
0.00%
Q3 2018$220,000
+4.8%
54,660
-2.0%
0.00%
Q2 2018$210,00055,7600.00%
Other shareholders
CORREVIO PHARMA CORP shareholders Q4 2019
NameSharesValueWeighting ↓
SUMMER ROAD LLC 250,000$103,0000.68%
Tamarack Advisers, LP 2,500,000$1,019,0000.23%
Virtu Financial LLC 287,972$118,0000.01%
ARS Investment Partners, LLC 147,818$61,0000.01%
Pacifica Partners Inc. 2,665$1,0000.00%
OXFORD ASSET MANAGEMENT LLP 116,653$48,0000.00%
K.J. Harrison & Partners Inc 12,860$5,0000.00%
TORONTO DOMINION BANK 153$00.00%
SCOTIA CAPITAL INC. 19,000$8,0000.00%
MORGAN STANLEY 99,852$41,0000.00%
View complete list of CORREVIO PHARMA CORP shareholders